SVB Wealth LLC Has $592,000 Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

SVB Wealth LLC reduced its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 30.5% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 27,289 shares of the pharmacy operator’s stock after selling 11,957 shares during the period. SVB Wealth LLC’s holdings in Walgreens Boots Alliance were worth $592,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Highlander Capital Management LLC bought a new position in Walgreens Boots Alliance in the fourth quarter valued at approximately $26,000. Pineridge Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth $26,000. Venturi Wealth Management LLC increased its holdings in Walgreens Boots Alliance by 1,241.8% in the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 981 shares during the last quarter. Rocky Mountain Advisers LLC bought a new position in Walgreens Boots Alliance during the fourth quarter worth about $30,000. Finally, Quest Partners LLC acquired a new position in shares of Walgreens Boots Alliance during the 4th quarter worth about $30,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of WBA traded up $0.12 during trading hours on Monday, hitting $11.94. The company had a trading volume of 15,445,610 shares, compared to its average volume of 15,732,755. The business has a fifty day moving average of $13.94 and a 200-day moving average of $18.12. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. The firm has a market cap of $10.31 billion, a price-to-earnings ratio of -1.75, a PEG ratio of 0.83 and a beta of 0.72. Walgreens Boots Alliance, Inc. has a 12 month low of $10.69 and a 12 month high of $30.79.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The firm had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. During the same quarter last year, the business posted $1.00 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 2.8% on a year-over-year basis. Equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 2.87 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Wednesday, August 21st will be given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 8.38%. The ex-dividend date is Wednesday, August 21st. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on WBA. Barclays decreased their price target on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a report on Tuesday, July 23rd. Evercore ISI lowered their price target on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating for the company in a report on Friday, June 28th. Royal Bank of Canada cut their price objective on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a report on Tuesday, July 2nd. TD Cowen decreased their price objective on Walgreens Boots Alliance from $35.00 to $22.00 and set a “buy” rating for the company in a research report on Monday, July 1st. Finally, JPMorgan Chase & Co. dropped their target price on shares of Walgreens Boots Alliance from $30.00 to $20.00 and set an “overweight” rating on the stock in a report on Monday, July 1st. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus target price of $16.86.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.